# Primary Care Amoxicillin Challenge

> **NCT05165212** · PHASE4 · WITHDRAWN · sponsor: **State University of New York at Buffalo**

## Conditions studied

- Amoxicillin Allergy

## Interventions

- **DRUG:** Amoxicillin

## Key facts

- **NCT ID:** NCT05165212
- **Lead sponsor:** State University of New York at Buffalo
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-12-31
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-01-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to host study at clinic site.
- **Last updated:** 2023-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05165212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05165212, "Primary Care Amoxicillin Challenge". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT05165212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*